Global Biopsy Devices Market Size 2024, Forecast To 2033

11 Mar, 2024

The biopsy devices market size has experienced robust growth in recent years, increasing from $2.87 billion in 2023 to $3.11 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. This growth in the historic period is attributed to the expansion of emerging markets, advancements in healthcare infrastructure, and the rise in the elderly population. The market is expected to continue its upward trajectory, reaching $4.29 billion in 2028 with a CAGR of 8.4%. Factors driving this growth in the forecast period include government investments in the healthcare sector, a surge in cancer cases, and an overall increase in healthcare expenditure. Noteworthy trends include technological advancements, the introduction of fully automatic biopsy systems, product innovations, the development of robot-assisted biopsy systems, and strategic partnerships, with increasing investments contributing to market expansion.

Global Biopsy Devices Market Key Driver

The expansion in the number of cancer cases has been a significant factor contributing to the growth of the biopsy devices market. Biopsy, a primary diagnostic approach used by doctors when cancer is suspected, plays a crucial role in identifying abnormalities in the body. The American Cancer Society reported that around 1.9 million new cancer cases were anticipated in the United States in 2022, with an estimated 609,360 cancer-related deaths. Specifically, projections for colorectal cancer cases in 2022 were approximately 151,030, expected to lead to roughly 52,550 deaths in 2023. In Canada, it was estimated that about 233,900 new cancer cases would be diagnosed in 2022, with breast cancer constituting approximately 25% of newly diagnosed cases in women. Lung cancer was expected to be the most prevalent type, with an estimated 30,000 new cases.

Get A Free Sample Of The Global Biopsy Devices Market Report

Global Biopsy Devices Market Segments

The biopsy devices market covered in this report is segmented –
1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products
2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies
3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications
4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User
By Geography:The regions covered in the biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain North America was the largest region in the biopsy devices market in 2023. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Major Biopsy Devices Industry Players

Becton Dickinson and Company (BD), Hologic, Inc., Danaher Corporation, Boston Scientific Corporation, Olympus Corporation, Cook Medical, Medtronic Inc, Cardinal Health, Argon Medical Devices Inc., Fujifilm Holdings Corp, A&T Corporation, BMA Co. Ltd., Transmed (China) Co., LTD, HaploX Biotechnology, Gene+sLab, Lepu Medical Technology, Digirad Corporation, CMR Naviscan Corporation, DDD Diagnostics, Philips Healthcare, Siemens Healthineers, Abbott Laboratories, Bangs Laboratories Inc, Roche Diagnostics, Cepheid, Devicor Medical Products, Braile Biomedica Ltd, B.Braun Medical Gulf, Stryker ESCS BV

Get The Full Global Biopsy Devices Market Report

Biopsy Devices Market Overview

The biopsy devices are used to extract sample cells or tissues from the patient's body to be examined to determine the presence of a disease.

Biopsy Devices Global Market Report 2023 provides data on the global biopsy devices market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The biopsy devices market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.